Equity Profile

COR

Cencora, Inc.

Health CareHealth Care Distributors$53.5B

Feb3Thu

Pre-Earnings Brief

UpcomingQ3-2026Pre-Market9:00 AM EST

Company Snapshot

Cencora, Inc. is a major player in the health care distribution sector, focusing on delivering essential medical products and services....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

$4.80

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and meet increasing demand in the health care sector.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

COR Q3-2026 Earnings Preview

Context

Company Snapshot

Cencora, Inc. is a major player in the health care distribution sector, focusing on delivering essential medical products and services. With a market cap of $52 billion, the company plays a crucial role in ensuring that health care providers have access to the medications and supplies they need, especially in a time when health care demand is high.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+3.76%

Avg Stock Reaction

-1.64%

Last Quarter Recap

In Q2-2026, Cencora reported an EPS of $4.75, slightly missing estimates. The stock reacted negatively, dropping 17.38% the following day.

Management Promises & Guidance

Focus on improving operational efficiencies.
Commitment to expanding product offerings.
Plans to enhance customer service and delivery times.

Expectations

Wall Street Expectations

Overall, analysts are cautious about Cencora's upcoming earnings, especially after the recent EPS miss. Investors are looking for signs of recovery and growth.

Bull Case

If Cencora can beat EPS estimates and show strong revenue growth, it could signal a turnaround, boosting investor confidence and stock price.

Bear Case

Conversely, if the company misses expectations again, it could raise concerns about its operational effectiveness and market position, leading to further declines.

Key Metrics to Watch

Earnings Per Share (EPS)

$4.80

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

Revenue Growth

N/A

Revenue growth reflects the company's ability to expand its market share and meet increasing demand in the health care sector.

Gross Margin

N/A

Gross margin indicates how efficiently Cencora is managing its costs relative to its sales, which is critical for profitability.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Cencora report an EPS of $4.80 or higher?

This number is crucial as it will determine if the company can regain investor confidence after recent misses.

What is the outlook for revenue growth in the coming quarters?

Investors will be looking for guidance on revenue trends to assess the company's ability to capitalize on market demand.

Edge

What the Street Is Missing

Why consensus could be wrong

The market may be underestimating Cencora's potential for recovery, especially given its strong historical EPS beat rate.

Supporting Evidence

Cencora has an 88% EPS beat rate historically, indicating a strong ability to exceed expectations.

Options are pricing a smaller move than the historical average, suggesting potential for a larger reaction.

Recent operational commitments could lead to improved efficiency and revenue growth.

Key Risk

If Cencora's EPS exceeds $4.80, it could challenge the current cautious sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical for Cencora, as it follows a pattern of recent misses and investor skepticism.

Bull Confirmed If

An EPS of $4.80 or better with positive revenue growth would confirm the bull case.

Bear Confirmed If

An EPS below $4.75 and negative revenue guidance would solidify the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±0.94%

Historical Avg

±5.6%

Pricing cheap

The options market is pricing a relatively small movement in the stock, suggesting that investors are uncertain about significant changes post-earnings.

Options are pricing ±0.9% while COR has averaged ±5.6% over the last 8 prints — setup is pricing cheap.

Detail

ATM IV

0.3%

30d HV

60.2%

Calls (13K)P/C Ratio: 0.19Puts (105K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Cencora beats expectations, history suggests a potential stock increase of about 0.61%, confirming a positive turnaround.

In-Line / Cautious

If results are in line but cautious, the stock may see muted movement, reflecting ongoing investor uncertainty.

Miss

A miss could lead to a significant decline, with history indicating an average drop of 17.38% following such outcomes.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on operational efficiencies and cost management strategies.
2Details on new product offerings and market expansion plans.
3Insights into customer service improvements and delivery timelines.
4Management's outlook on revenue growth for the next quarter.
5Responses to analyst questions regarding recent performance trends.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Cirrus Logic, Inc.

Company Snapshot

Cencora, Inc. is a major player in the health care distribution sector, focusing on delivering essential medical products and services....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

$4.80

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and meet increasing demand in the health care sector.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

COR Q3-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+3.76%

Avg Stock Reaction

-1.64%

Last Quarter Recap

In Q2-2026, Cencora reported an EPS of $4.75, slightly missing estimates. The stock reacted negatively, dropping 17.38% the following day.

Management Promises & Guidance

Focus on improving operational efficiencies.
Commitment to expanding product offerings.
Plans to enhance customer service and delivery times.

Expectations

Wall Street Expectations

Overall, analysts are cautious about Cencora's upcoming earnings, especially after the recent EPS miss. Investors are looking for signs of recovery and growth.

Bull Case

If Cencora can beat EPS estimates and show strong revenue growth, it could signal a turnaround, boosting investor confidence and stock price.

Bear Case

Conversely, if the company misses expectations again, it could raise concerns about its operational effectiveness and market position, leading to further declines.

Key Metrics to Watch

Earnings Per Share (EPS)

$4.80

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

Revenue Growth

N/A

Revenue growth reflects the company's ability to expand its market share and meet increasing demand in the health care sector.

Gross Margin

N/A

Gross margin indicates how efficiently Cencora is managing its costs relative to its sales, which is critical for profitability.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Cencora report an EPS of $4.80 or higher?

This number is crucial as it will determine if the company can regain investor confidence after recent misses.

What is the outlook for revenue growth in the coming quarters?

Investors will be looking for guidance on revenue trends to assess the company's ability to capitalize on market demand.

Edge

What the Street Is Missing

Why consensus could be wrong

The market may be underestimating Cencora's potential for recovery, especially given its strong historical EPS beat rate.

Supporting Evidence

Cencora has an 88% EPS beat rate historically, indicating a strong ability to exceed expectations.

Options are pricing a smaller move than the historical average, suggesting potential for a larger reaction.

Recent operational commitments could lead to improved efficiency and revenue growth.

Key Risk

If Cencora's EPS exceeds $4.80, it could challenge the current cautious sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical for Cencora, as it follows a pattern of recent misses and investor skepticism.

Bull Confirmed If

An EPS of $4.80 or better with positive revenue growth would confirm the bull case.

Bear Confirmed If

An EPS below $4.75 and negative revenue guidance would solidify the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±0.94%

Historical Avg

±5.6%

Pricing cheap

The options market is pricing a relatively small movement in the stock, suggesting that investors are uncertain about significant changes post-earnings.

Options are pricing ±0.9% while COR has averaged ±5.6% over the last 8 prints — setup is pricing cheap.

Detail

ATM IV

0.3%

30d HV

60.2%

Calls (13K)P/C Ratio: 0.19Puts (105K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Cencora beats expectations, history suggests a potential stock increase of about 0.61%, confirming a positive turnaround.

In-Line / Cautious

If results are in line but cautious, the stock may see muted movement, reflecting ongoing investor uncertainty.

Miss

A miss could lead to a significant decline, with history indicating an average drop of 17.38% following such outcomes.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on operational efficiencies and cost management strategies.
2Details on new product offerings and market expansion plans.
3Insights into customer service improvements and delivery timelines.
4Management's outlook on revenue growth for the next quarter.
5Responses to analyst questions regarding recent performance trends.